Thyroid Gland Disorders Treatment Market Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2017 - 2025

Feb 2018| TMR198A| Transparency

Report Highlights

Global Thyroid Gland Disorders Treatment Market: Overview

This report on the thyroid gland disorders treatment market analyzes the current and future scenario of the global market. Increasing incidence of thyroid gland disorders. Government regulations and initiatives for increasing awareness about thyroid gland disorders treatment are the major drivers of the global Thyroid Gland Disorders Treatment Market.

The thyroid gland disorders treatment market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on Disorders, and geography. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the market overview section. In addition, the section comprises competitive matrix and company profiles with business overview to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis, by geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global thyroid gland disorders treatment market.

Global Thyroid Gland Disorders Treatment Market: Key Segments

Based on Disorders, the market has been segmented into hypothyroidism and hyperthyroidism. The disorders market segments have been analyzed based on available approved treatments for hypothyroidism and hyperthyroidism, cost-effectiveness, and preference for industries. Furthermore, Hypothyroidism is categorized into Levothyroxine and Liothyronine, where hyperthyroidism is categorized into Imidazole and Propacil. The market size and forecast for each of these segments have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year.

Global Thyroid Gland Disorders Treatment Market: Regional Outlook

Geographically, the global thyroid gland disorders treatment market has been categorized into five major regions and the key countries in the respective region: North America (the U.S., Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, Australia & New Zealand and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa (South Africa, GCC countries, Israel, and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in Report

The report also profiles major players in the global thyroid gland disorders treatment market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. The major players in the Thyroid Gland Disorders Treatment Market are Merck KGaA, Pfizer, Inc., Takeda Pharmaceutical Company Limited, ALLERGAN, Sanofi S.A., AbbVie Inc., Lannett Company, Inc., Aspen, Novartis AG, Mylan N.V., and Others.

The global thyroid gland disorders treatment market is segmented as given below:

Global Thyroid Gland Disorders Treatment Market Revenue, by Disorders, 2015–2025
Hypothyroidism
Levothyroxine
Liothyronine
Hyperthyroidism
Imidazole
Propacil
Global Thyroid Gland Disorders Treatment Market Revenue, By Geography, 2015–2025
North America
U.S.
Canada
Europe
Germany
U.K.
Italy
France
Spain
Rest of Europe
Asia Pacific
India
China
Japan
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC countries
South Africa
Israel
Rest of Middle East & Africa

  • Table 1 : Global Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Disorder, 2015–2025
  • Table 2 : Global Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Hypothyroidism Drug Class,
  • Table 3 : Global Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Hyperthyroidism Drug Class,
  • Table 4 : Global Thyroid Gland Disorders Treatment Market Size (US$ Mn) Forecast, by Region, 2015–2025
  • Table 5 : North America Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Disorders, 2015–2025
  • Table 6 : North America Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Hypothyroidism Drug Class, 2015–2025
  • Table 7 : North America Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Hyperthyroidism Drug Class, 2015–2025
  • Table 8 : North America Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Country, 2015–2025
  • Table 9 : Europe Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Disorder, 2015–2025
  • Table 10 : Europe Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Hypothyroidism Drug Class, 2015–2025
  • Table 11 : Europe Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Hyperthyroidism Drug Class, 2015–2025
  • Table 12 : Europe Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
  • Table 13 : Asia Pacific Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Disorder, 2015–2025
  • Table 14 : Asia Pacific Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Hypothyroidism Drug Class, 2015–2025
  • Table 15 : Asia Pacific Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Hyperthyroidism Drug Class, 2015–2025
  • Table 16 : Asia Pacific Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
  • Table 17 : Latin America Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Disorder, 2015–2025
  • Table 18 : Latin America Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Hypothyroidism Drug Class, 2015–2025
  • Table 19 : Latin America Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Hyperthyroidism Drug Class, 2015–2025
  • Table 20 : Latin America Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
  • Table 21 : Middle East & Africa Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Disorders, 2015–2025
  • Table 22 : Middle East & Africa Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Hypothyroidism Drug Class, 2015–2025
  • Table 23 : Middle East & Africa Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Hyperthyroidism Drug Class, 2015–2025
  • Table 24 : Middle East & Africa Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–202
  • Figure 1 : Global Thyroid Gland Disorders Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2025
  • Figure 2 : Global Thyroid Gland Disorders Market Value Share, by Disorders (2016)
  • Figure 3 : Global Thyroid Gland Disorders Market Value Share, by Hypothyroidism Drug Class (2016)
  • Figure 4 : Global Thyroid Gland Disorders Market Value Share, by Region (2016)
  • Figure 5 : Global Thyroid Gland Disorders Market Value Share, by Hyperthyroidism Drug Class (2016)
  • Figure 6 : Global Thyroid Gland Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth, by Hypothyroidism, 2015–2025
  • Figure 7 : Global Thyroid Gland Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth, by Hyperthyroidism, 2015–2025
  • Figure 8 : Global Thyroid Gland Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth, by Levothyroxine, 2015–2025
  • Figure 9 : Global Thyroid Gland Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth, by Liothyronine, 2015–2025
  • Figure 10 : Global Thyroid Gland Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth, by Imidazole, 2015–2025
  • Figure 11 : Global Thyroid Gland Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth, by Propacil, 2015–2025
  • Figure 12 : Global Thyroid Gland Disorders Treatment Market Value Share Analysis, by Disorder, 2016 and 2025
  • Figure 13 : Global Thyroid Gland Disorders Treatment Market Value Share Analysis, by Hypothyroidism Drug Class, 2016 and 2025
  • Figure 14 : Global Thyroid Gland Disorders Treatment Market Value Share Analysis, by Hyperthyroidism Drug Class, 2016 and 2025
  • Figure 15 : Global Thyroid Gland Disorders Treatment Market Attractiveness Analysis, by Disorder
  • Figure 16 : Global Thyroid Gland Disorders Treatment Market Value Share Analysis, by Region, 2016 and 2025
  • Figure 17 : Global Thyroid Gland Disorders Treatment Market Attractiveness Analysis, by Region
  • Figure 18 : North America Thyroid Gland Disorders Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth, 2015–2025
  • Figure 19 : North America Market Attractiveness Analysis, by Country
  • Figure 20 : North America Thyroid Gland Disorders Treatment Market Value Share Analysis, by Disorders, 2016 and 2025
  • Figure 21 : North America Thyroid Gland Disorders Treatment Market Value Share Analysis, by Hypothyroidism Drug Class, 2016 and 2025
  • Figure 22 : North America Thyroid Gland Disorders Treatment Market Value Share Analysis, by Hyperthyroidism Drug Class, 2016 and 2025
  • Figure 23 : North America Thyroid Gland Disorders Treatment Market Value Share Analysis, by Country, 2016 and 2025
  • Figure 24 : North America Thyroid Gland Disorders Treatment Market Attractiveness Analysis, by Disorder
  • Figure 25 : Europe Thyroid Gland Disorders Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth, 2015–2025
  • Figure 26 : Europe Market Attractiveness Analysis, by Country
  • Figure 27 : Europe Thyroid Gland Disorders Treatment Market Value Share Analysis, by Disorder, 2016 and 2025
  • Figure 28 : Europe Thyroid Gland Disorders Treatment Market Value Share Analysis, by Hypothyroidism Drug Class, 2016 and 2025
  • Figure 29 : Europe Thyroid Gland Disorders Treatment Market Value Share Analysis, by Hyperthyroidism Drug Class, 2016 and 2025
  • Figure 30 : Europe Thyroid Gland Disorders Treatment Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
  • Figure 31 : Europe Thyroid Gland Disorders Treatment Market Attractiveness Analysis, by Disorder, 2015–2025
  • Figure 32 : Asia Pacific Thyroid Gland Disorders Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth, 2015–2025
  • Figure 33 : Asia Pacific Market Attractiveness Analysis, by Country/Sub-region
  • Figure 34 : Asia Pacific Thyroid Gland Disorders Treatment Market Value Share Analysis, by Disorder, 2016 and 2025
  • Figure 35 : Asia Pacific Thyroid Gland Disorders Treatment Market Value Share Analysis, by Hypothyroidism Drug Class, 2016 and 2025
  • Figure 36 : Asia Pacific Thyroid Gland Disorders Treatment Market Value Share Analysis, by Hyperthyroidism Drug Class, 2016 and 2025
  • Figure 37 : Asia Pacific Thyroid Gland Disorders Treatment Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
  • Figure 38 : Asia Pacific Thyroid Gland Disorders Treatment Market Attractiveness Analysis, by Disorders
  • Figure 39 : Latin America Thyroid Gland Disorders Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth, 2015–2025
  • Figure 40 : Latin America Market Attractiveness Analysis, by Country/Sub-region
  • Figure 41 : Latin America Thyroid Gland Disorders Treatment Market Value Share Analysis, by Disorder, 2016 and 2025
  • Figure 42 : Latin America Thyroid Gland Disorders Treatment Market Value Share Analysis, by Hypothyroidism Drug Class, 2016 and 2025
  • Figure 43 : Latin America Thyroid Gland Disorders Treatment Market Value Share Analysis, by Hyperthyroidism Drug Class, 2016 and 2025
  • Figure 44 : Latin America Thyroid Gland Disorders Treatment Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
  • Figure 45 : Latin America Thyroid Gland Disorders Treatment Market Attractiveness Analysis, by Disorder
  • Figure 46 : Middle East & Africa Thyroid Gland Disorders Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth, 2015–2025
  • Figure 47 : Middle East & Africa Market Attractiveness Analysis, by Country/Sub-region
  • Figure 48 : Middle East & Africa Thyroid Gland Disorders Treatment Market Value Share Analysis, by Disorder, 2016 and 2025
  • Figure 49 : Middle East & Africa Thyroid Gland Disorders Treatment Market Value Share Analysis, by Hypothyroidism Drug Class, 2016 and 2025
  • Figure 50 : Middle East & Africa Thyroid Gland Disorders Treatment Market Value Share Analysis, by Hyperthyroidism Drug Class, 2016 and 2025
  • Figure 51 : Middle East & Africa Thyroid Gland Disorders Treatment Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
  • Figure 52 : Middle East & Africa Thyroid Gland Disorders Treatment Market Attractiveness Analysis, by Disorder
  • Figure 53 : Global Thyroid Gland Disorders Treatment Market Company Share Analysis (2016)
  • Figure 54 : Merck KGaA Revenue (US$ Bn) & Y-o-Y Growth (%), 2013–2016
  • Figure 55 : Merck KGaA Breakdown of Net Sales, by Region, 2016
  • Figure 56 : Breakdown of Net Sales, by Business Segment, 2016
  • Figure 57 : Merck KGaA R&D Expenses (US$ Bn) & Y-o-Y Growth (%), 2014–2016
  • Figure 58 : Pfizer, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2016
  • Figure 59 : Pfizer, Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2013–2016
  • Figure 60 : Pfizer, Inc. Breakdown of Net Sales, by Region, 2016
  • Figure 61 : Pfizer, Inc. Sales & Marketing Expenses (US$ Mn) and Y-o-Y Growth (%), 2013–2016
  • Figure 62 : Takeda Pharmaceutical Company Limited Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2016
  • Figure 63 : Takeda Pharmaceutical Company Limited R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2013–2016
  • Figure 64 : Takeda Pharmaceutical Company Limited Breakdown of Net Sales, by Region
  • Figure 65 : Takeda Pharmaceutical Company Limited Sales & Marketing Expenses (US$ Mn) and Y-o-Y Growth (%), 2013–2016
  • Figure 66 : ALLERGAN Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2016
  • Figure 67 : ALLERGAN R&D Spending and Sales & Marketing Expenses – Company Level, 2015–2016
  • Figure 68 : ALLERGAN Breakdown of Net Sales, by Operating Segment, 2016
  • Figure 69 : Sanofi S.A. Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2016
  • Figure 70 : Sanofi S.A. R&D Spending and Sales & Marketing Expenses – Company Level, 2014–2016
  • Figure 71 : Sanofi S.A. Breakdown of Net Sales, by Region, 2016
  • Figure 72 : Sanofi S.A. Breakdown of Net Sales, by Business Segment, 2016
  • Figure 73 : AbbVie Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2016
  • Figure 74 : AbbVie Inc. R&D Expenses and Sales & Marketing Expenses– Company Level, 2015–2016
  • Figure 75 : AbbVie Inc. Breakdown of Net Sales, by Region, 2016
  • Figure 76 : AbbVie Inc. Breakdown of Net Sales, by Major Brands, 2016
  • Figure 77 : Lannett Company, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2016
  • Figure 78 : Lannett Company, Inc. Breakdown of Net Sales, by Business Segments, 2016
  • Figure 79 : Lannett Company, Inc. Breakdown of Net Sales, by Customer Distribution Channel, 2016
  • Figure 80 : Aspen Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
  • Figure 81 : Aspen R&D Expenses and Sales & Marketing Expenses(%) – Company Level, 2015–2016
  • Figure 82 : Aspen Breakdown of Net Sales, By Region 2016
  • Figure 83 : Aspen Breakdown of Net Sales, (Overall Company Level), 2016
  • Figure 84 : Novartis AG Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
  • Figure 85 : Novartis AG R&D Expenses and Sales & Marketing Expenses(%) – Company Level, 2015–2016
  • Figure 86 : Novartis AG Breakdown of Net Sales, By Region 2016
  • Figure 87 : Novartis AG Breakdown of Net Sales, Business Segments, 2016
  • Figure 88 : Mylan N.V. Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
  • Figure 89 : Mylan N.V. R&D Expenses and Sales & Marketing Expenses(%) – Company Level, 2015–2016
  • Figure 90 : Mylan N.V. Breakdown of Net Sales, By Region 2016
  • Figure 91 : Mylan N.V. Breakdown of Net Sales, Business Segments, 2016

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report